Seasoned investment executive with deep experience in European private equity and corporate finance, Pierre-Jean FROGNET brings operational and deal-making expertise across growth and buyout situations. He has held senior roles leading deal teams, portfolio oversight and value-creation programs for mid-market companies, focusing on industrials, TMT and services. Educated in finance and business, he is known for disciplined underwriting, active board engagement and driving strategic exits for institutional investors and family offices.
Seasoned investment executive with deep experience in European private equity and corporate finance, Pierre-Jean FROGNET brings operational and deal-making expertise across growth and buyout situations. He has held senior roles leading deal teams, portfolio oversight and value-creation programs for mid-market companies, focusing on industrials, TMT and services. Educated in finance and business, he is known for disciplined underwriting, active board engagement and driving strategic exits for institutional investors and family offices.
Combines a private-equity practitioner’s focus on disciplined underwriting with an operator’s emphasis on hands-on value creation. Targets mid‑market buyouts and growth capital situations in industrials, TMT and services where operational improvement, margin expansion and selective add‑on consolidation can drive returns. Prefers sponsor-friendly deal structures, thorough commercial and operational due diligence, and a three-to-seven year horizon for active board engagement and strategic exits. Risk management centers on cash‑flow durability, management alignment and staged value‑creation milestones.
Combines a private-equity practitioner’s focus on disciplined underwriting with an operator’s emphasis on hands-on value creation. Targets mid‑market buyouts and growth capital situations in industrials, TMT and services where operational improvement, margin expansion and selective add‑on consolidation can drive returns. Prefers sponsor-friendly deal structures, thorough commercial and operational due diligence, and a three-to-seven year horizon for active board engagement and strategic exits. Risk management centers on cash‑flow durability, management alignment and staged value‑creation milestones.
| Trades 2689 | Longs Won 1612/2689 59% | Profit Factor 3.04 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $5.4M |
| Average Win $813,842.4 | Best Trade (Aug 28) $210.2M | Sharpe Ratio -10.7 |
| Average Loss -$400,597.45 | Worst Trade (Mar 31) -$112.52M | Z-Score 0.93 (64.9%) |
| Commissions $0 | Avg. Trade Length 1y 6m 1w 2d | Expectancy $327,434.18 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% | 1.86% |
| Consecutive Losing Trades | 4,202 | 3,782 | 3,361 | 2,941 | 2,521 | 2,101 | 1,681 | 1,261 | 840 | 420 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 2,431 | $284,378.38 | $336,377.47 | - | $51,999.09 | 18.29% | -0.245% |
AAL American Airlines Group Inc. | 500 | $7,298.86 | $7,635 | - | $336.14 | 4.61% | -1.037% |
ABBV AbbVie Inc. | 1,600 | $315,967.72 | $401,504 | - | $85,536.28 | 27.07% | -2.513% |
ADBE Adobe Inc. | 7,741 | $3.14M | $1.94M | - | -$1.2M | -38.21% | +1.013% |
AMT American Tower Corporation | 144,545 | $29.22M | $25.06M | - | -$4.16M | -14.24% | -0.631% |
APP AppLovin Corporation Class A Common Stock | 758 | $481,150.3 | $300,092.19 | - | -$181,058.11 | -37.63% | -1.973% |
ASML ASML Holding N.V. New York Registry Shares | 315 | $297,010.82 | $513,135 | - | $216,124.18 | 72.77% | -1.359% |
ATAI AtaiBeckley Inc. | 1,000 | $3,540 | $7,180 | - | $3,640 | 102.82% | 0.0 |
AVGO Broadcom Inc. | 121,848 | $40.08M | $47.43M | - | $7.35M | 18.34% | +0.371% |
B BARRICK MINING CORP Common Stock (ABR0) | 10,882 | $226,095.02 | $399,695.86 | - | $173,600.84 | 76.78% | -2.573% |
BABA Alibaba Group Holding Limited SP ADR | 33,585 | $3.7M | $4.11M | - | $406,122.31 | 10.98% | +5.098% |
BIIB Biogen Inc. | 195 | $29,819.43 | $39,575.25 | - | $9,755.82 | 32.72% | -2.395% |
BKNG Booking Holdings Inc. | 5,350 | $718,349.87 | $1.03M | - | $313,665.08 | 43.66% | -0.176% |
BMNR Bitmine Immersion Technologies, Inc. | 575 | $29,860 | $9,936 | - | -$19,924 | -66.72% | -4.425% |
BMY Bristol-Myers Squibb Company | 37,760 | $2.22M | $2.47M | - | $241,461.49 | 10.85% | +0.694% |
BNTX BioNTech SE | 576 | $63,836.21 | $52,174.08 | - | -$11,662.13 | -18.27% | -2.445% |
BSX Boston Scientific Corporation | 10,713 | $672,240.8 | $500,618.49 | - | -$171,622.31 | -25.53% | +1.587% |
BTI British American Tobacco p.l.c. ADR | 4,500 | $263,115 | $272,925 | - | $9,810 | 3.73% | -1.686% |
BUD Anheuser-Busch InBev S.A. ADR | 3,290 | $206,749.95 | $284,519.2 | - | $77,769.25 | 37.62% | +0.395% |
CAT Caterpillar Inc. | 4,565 | $2.07M | $3.72M | - | $1.65M | 79.46% | +0.701% |